NLRP3 and Alzheimer disease: Targeting the nucleotide-binding oligomerization domain–like receptor pyrin domain containing 3 (NLRP3)–caspase-1 inflammasome cascade with its inhibitor was verified to prevent AD through mitigating smooth muscle cell contractile protein degradation and extracellular matrix destruction (39, 40).